Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2026-03-03 00:00:00 ET · period of report 2026-02-27 · accession 0001193125-26-088730 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-03 | 2026-02-27 | PHAT | Breedlove Robert Charles | Principal Accounting Off | A - Grant | $0.00 | +15.8K | 62.9K | +34% | $0 |
| M | 2026-03-03 | 2026-02-27 | PHAT | Breedlove Robert Charles | Principal Accounting Off | F - Tax | $12.56 | -1,378 | 61.5K | -2% | -$17.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-27 | A | A | 13,000 | $0.00 | 60,068 | D | — | — | (F1) Represents restricted stock units ("RSUs") granted on February 27, 2026. 1/3 of the total number of RSUs granted vest on each of the first three anniversaries of February 27, 2026, the vesting commencement date, subject to the Reporting Person's continued service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer. |
| 2 | Common | Common Stock | 2026-02-27 | A | A | 2,790 | $0.00 | 62,858 | D | — | — | (F2) Represents shares issued upon vesting of performance stock units granted to the reporting person on February 27, 2025 based on the achievement of performance criteria determined to be satisfied on February 27, 2026. |
| 3 | Common | Common Stock | 2026-02-27 | F | D | 964 | $12.56 | 61,894 | D | — | — | |
| 4 | Common | Common Stock | 2026-02-27 | F | D | 414 | $12.56 | 61,480 | D | — | — |